Cancer Research  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 367-372, January 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cinatl, J.
Right arrow Articles by Doerr, H. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cinatl, J., Jr.
Right arrow Articles by Doerr, H. W.

Persistent Human Cytomegalovirus Infection Induces Drug Resistance and Alteration of Programmed Cell Death in Human Neuroblastoma Cells1

Jindrich Cinatl, Jr.2, Jaroslav Cinatl, Jens-Uwe Vogel, Ruslan Kotchetkov, Pablo Hernáiz Driever, Hana Kabickova, Bernhard Kornhuber, Dirk Schwabe and Hans Wilhelm Doerr

Zentrum der Hygiene, Institut für Medizinische Virologie [Ji. C., Ja. C., J-U. V., R. K., H. W. D.], Zentrum für Kinderheilkunde und Jugendmedizin, Abteilung Pädiatrische Hämatologie und Onkologie [Ja. C., J-U. V., R. K., B. K., D. S.], and Abteilung Pädiatrische Neurologie [P. H. D.], Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany, and Clinical KlinLab Stresovice, Praha 6, Czech Republic [H. K.]

Infection with human cytomegalovirus (HCMV) is a common and generally asymptomatic affection in childhood. Its role in neuroblastoma (NB) patients has not yet been elucidated. As evidence grows that HCMV interacts with apoptotic signaling due to the interaction of HCMV gene products with cellular proteins of apoptotic pathways, we used human NB cell line UKF-NB-2 persistently infected with HCMV strain AD169 to study the effects of long-term HCMV infection on programmed cell death of neuroectodermal tumor cells. The cells designated UKF-NB-2AD169 continued to produce infectious virus in successive subcultures over a period of more than 1 year. Up to 20% of cells expressed viral genes or produced infectious virus after initiation of infection. UKF-NB-2AD169 cells were significantly less sensitive to the cytotoxic agents cisplatinum and etoposide than parental (noninfected) UKF-NB-2 cells. These effects were associated with decreased ability of UKF-NB-2AD169 cells to undergo apoptosis and continuous viral replication. UKF-NB-2AD169 cells showed increased levels of antiapoptosis Bcl-2 protein (up to 12-fold), whereas expression of p53 and c-myc was not changed. Treatment of UKF-NB-2AD169 cells with ganciclovir, abolishing virus production, reestablished sensitivity to chemotherapy, lowered Bcl-2 expression, and facilitated inducibility of apoptosis to the level of the parental cell line. The results demonstrate that persistent HCMV infection confers resistance to cytotoxic agents on neuroectodermal tumor cells and protects from apoptosis, probably due to increased levels of Bcl-2 protein. Hence, it is conceivable that HCMV infection before or during tumorigenesis may contribute in some NB patients to failure of therapy.

1 This work was supported by the foundations Hilfe für krebskranke Kinder Frankfurt am Main e.V., Frankfurter Stiftung für krebskranke Kinder, and Paul und Ursula Klein-Stiftung.

2 To whom requests for reprints should be addressed, at Institut für Medizinische Virologie, Zentrum der Hygiene, Klinikum der Johann Wolfgang Goethe-Universität, Paul-Ehrlich-Straße 40, D-60596 Frankfurt am Main, Germany.

Received 8/ 5/97. Accepted 11/13/97.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. H. Luo and E. A. Fortunato
Long-Term Infection and Shedding of Human Cytomegalovirus in T98G Glioblastoma Cells
J. Virol., October 1, 2007; 81(19): 10424 - 10436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Allart, H. Martin, C. Detraves, J. Terrasson, D. Caput, and C. Davrinche
Human Cytomegalovirus Induces Drug Resistance and Alteration of Programmed Cell Death by Accumulation of Delta N-p73alpha
J. Biol. Chem., August 2, 2002; 277(32): 29063 - 29068.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Cinatl Jr, S. Margraf, J.-U. Vogel, M. Scholz, J. Cinatl, and H. W. Doerr
Human Cytomegalovirus Circumvents NF-{kappa}B Dependence in Retinal Pigment Epithelial Cells
J. Immunol., August 15, 2001; 167(4): 1900 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cinatl Jr., R. Kotchetkov, M. Scholz, J. Cinatl, J.-U. Vogel, P. H. Driever, and H. W. Doerr
Human Cytomegalovirus Infection Decreases Expression of Thrombospondin-1 Independent of the Tumor Suppressor Protein p53
Am. J. Pathol., July 1, 1999; 155(1): 285 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.